Adamis Pharmaceuticals Corporation Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 05/15/2023 | 14.50 M | $1.68 M | 100.00% | 9.48% |
VANGUARD GROUP INC | 07/14/2023 | 6.48 M | $751.49 K | 0.00% | 4.24% |
BLACKROCK INC. | 05/12/2023 | 2.77 M | $320.69 K | -0.03% | 1.81% |
GEODE CAPITAL MANAGEMENT, LLC | 05/15/2023 | 1.33 M | $153.76 K | 0.00% | 0.87% |
STATE STREET CORP | 05/15/2023 | 475.37 K | $55.10 K | 0.00% | 0.31% |
CITADEL ADVISORS LLC | 05/15/2023 | 327.17 K | $37.92 K | 100.00% | 0.21% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/09/2023 | 268.78 K | $31.00 K | 4.01% | 0.18% |
NORTHERN TRUST CORP | 05/15/2023 | 244.63 K | $28.35 K | 0.00% | 0.16% |
HRT FINANCIAL LP | 05/12/2023 | 143.86 K | $16.00 K | 991.00% | 0.09% |
UBS GROUP AG | 05/12/2023 | 128.20 K | $14.87 K | 213.01% | 0.08% |
MORGAN STANLEY | 05/15/2023 | 114.22 K | $13.24 K | 11.41% | 0.07% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 05/11/2023 | 100.00 K | $11.59 K | 0.00% | 0.07% |
CAPITAL CS GROUP, LLC | 04/07/2023 | 94.10 K | $10.91 K | 2.26% | 0.06% |
BANK OF NEW YORK MELLON CORP | 05/09/2023 | 84.00 K | $9.74 K | 0.00% | 0.05% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 05/11/2023 | 69.70 K | $8.00 K | -0.43% | 0.05% |
VERDENCE CAPITAL ADVISORS LLC | 04/24/2023 | 58.38 K | $6.77 K | 0.00% | 0.04% |
LIDO ADVISORS, LLC | 05/15/2023 | 46.72 K | $5.42 K | 0.00% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2023 | 39.60 K | $4.75 K | -86.12% | 0.03% |
REGIONS FINANCIAL CORP | 05/12/2023 | 34.50 K | $4.00 K | 0.00% | 0.02% |
AFFINITY CAPITAL ADVISORS, LLC | 04/11/2023 | 30.32 K | $3.51 K | 17.59% | 0.02% |
BANK OF AMERICA CORP /DE/ | 05/12/2023 | 25.74 K | $2.96 K | -35.38% | 0.02% |
TWO SIGMA SECURITIES, LLC | 05/15/2023 | 24.63 K | $2.85 K | -11.95% | 0.02% |
GLOBAL STRATEGIC INVESTMENT SOLUTIONS, LLC | 04/20/2023 | 23.00 K | $2.67 K | 0.00% | 0.02% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2023 | 22.08 K | $2.56 K | 58.17% | 0.01% |
STONEBRIDGE CAPITAL ADVISORS LLC | 05/12/2023 | 22.00 K | $2.55 K | 0.00% | 0.01% |
B. RILEY WEALTH ADVISORS, INC. | 05/17/2023 | 20.00 K | $2.32 K | 0.00% | 0.01% |
RVW WEALTH, LLC | 04/11/2023 | 19.00 K | $2.20 K | 0.00% | 0.01% |
VICTORY CAPITAL MANAGEMENT INC | 05/02/2023 | 16.64 K | $1.93 K | -1.29% | 0.01% |
CITADEL ADVISORS LLC | 05/15/2023 | 14.90 K | $1.73 K | -58.95% | 0.01% |
HARBOUR INVESTMENTS, INC. | 05/15/2023 | 12.86 K | $1.49 K | 0.00% | 0.01% |
OPPENHEIMER & CO INC | 05/10/2023 | 12.00 K | $1.39 K | 0.00% | 0.01% |
WELLS FARGO & COMPANY/MN | 05/12/2023 | 11.04 K | $1.28 K | 981.00% | 0.01% |
WOLFF WIESE MAGANA LLC | 04/18/2023 | 10.74 K | $1.25 K | 0.00% | 0.01% |
MGO ONE SEVEN LLC | 05/08/2023 | 10.62 K | $1.23 K | 0.00% | 0.01% |
JANNEY MONTGOMERY SCOTT LLC | 04/28/2023 | 10.00 K | $1.00 K | 0.00% | 0.01% |
SIMPLEX TRADING, LLC | 04/27/2023 | 8.93 K | $1.00 K | 100.00% | 0.01% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2023 | 6.19 K | $718 | -2.15% | 0.00% |
GROUP ONE TRADING, L.P. | 05/12/2023 | 5.61 K | $650 | 100.00% | 0.00% |
TIMESCALE FINANCIAL, INC. | 04/24/2023 | 5.10 K | $591 | 0.00% | 0.00% |
FOUNDERS CAPITAL MANAGEMENT | 04/12/2023 | 5.00 K | $1.00 K | 0.00% | 0.00% |
CITADEL ADVISORS LLC | 05/15/2023 | 4.20 K | $487 | -33.33% | 0.00% |
ALLWORTH FINANCIAL LP | 04/18/2023 | 3.53 K | $410 | 100.00% | 0.00% |
NEWEDGE ADVISORS, LLC | 05/12/2023 | 2.70 K | $313 | 100.00% | 0.00% |
HOLLENCREST CAPITAL MANAGEMENT | 05/16/2023 | 2.00 K | $232 | 0.00% | 0.00% |
BELPOINTE ASSET MANAGEMENT LLC | 05/15/2023 | 900 | $104 | 0.00% | 0.00% |
SIGNATUREFD, LLC | 04/28/2023 | 863 | $100 | 0.00% | 0.00% |
JPMORGAN CHASE & CO | 05/18/2023 | 392 | $0 | -2.49% | 0.00% |
CAPE INVESTMENT ADVISORY, INC. | 10/12/2023 | 100 | $12 | 100.00% | 0.00% |
ROYAL BANK OF CANADA | 05/15/2023 | 92 | $0 | 64.29% | 0.00% |
WINCH ADVISORY SERVICES, LLC | 05/10/2023 | 73 | $0 | 0.00% | 0.00% |
Adamis Pharmaceuticals Corporation institutional Ownership - FAQ's
During the previous two years, 11 institutional investors and hedge funds held shares of Adamis Pharmaceuticals Corporation. The most heavily invested institutionals were:
TimeScale Financial, Inc.: 0
LADENBURG THALMANN FINANCIAL SERVICES INC.: 8,171
Sterling Global Strategies LLC: 12,240
FNY Managed Accounts LLC: 800
SII INVESTMENTS INC/WI: 10,000
Virtu KCG Holdings LLC: 38,474
18.04% of Adamis Pharmaceuticals Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 267.93 K shares in the last 24 months. This purchase volume represents approximately $208.99 K in transactions.